Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
273.8 EUR | -0.26% | -2.18% | -9.34% |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The firm trades with high earnings multiples: 27.3 times its 2024 earnings per share.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.34% | 17.5B | - | ||
+7.77% | 218B | B | ||
+10.16% | 189B | B- | ||
+26.21% | 151B | B- | ||
+32.78% | 113B | A- | ||
+1.98% | 64.02B | A- | ||
+14.48% | 52.6B | B+ | ||
+2.92% | 49.85B | B+ | ||
-6.60% | 37.89B | A | ||
-1.07% | 34.92B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WAT Stock
- WAZ Stock
- Ratings Waters Corporation